- Alternative title
-
Chronic effects of PCSK9 inhibitors on macro- and microcurrent pathways.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Deutsch
- Notes
-
Düsseldorf, Heinrich-Heine-Universität, Dissertation, 2023
- Classification
-
Medizin, Gesundheit
- Event
-
Veröffentlichung
- (where)
-
Düsseldorf
- (who)
-
Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf
- (when)
-
2023
- Creator
- Contributor
-
Sansone, Roberto
Suschek, Christoph
- URN
-
urn:nbn:de:hbz:061-20230901-133806-9
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schremmer, Johanna Maria
- Sansone, Roberto
- Suschek, Christoph
- Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf
Time of origin
- 2023
Other Objects (12)
Synthesis of a PCSK9 Inhibitor
PCSK9 inhibitors in the prevention of cardiovascular disease
Evolocumab (Repatha) - PCSK9-Inhibitor : kardiovaskuläre Risikioreduktion durch konsequente Lipidsenkung
Clinical Pharmacokinetics and Pharmacodynamics of Evolocumab, a PCSK9 Inhibitor
PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
Berberine : Ins and outs of a nature-made PCSK9 inhibitor
Kardiomyozytäre Effekte der Proprotein Konvertase Subtilisin/Kexin Typ 9 (PCSK9)
Impact of PCSK9 inhibitors in glycaemic control and new-onset diabetes
PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention
Gene Therapy Targeting PCSK9
Makro Fotografie
Makro-Fotografie
Synthesis of a PCSK9 Inhibitor
PCSK9 inhibitors in the prevention of cardiovascular disease
Evolocumab (Repatha) - PCSK9-Inhibitor : kardiovaskuläre Risikioreduktion durch konsequente Lipidsenkung
Clinical Pharmacokinetics and Pharmacodynamics of Evolocumab, a PCSK9 Inhibitor
PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
Berberine : Ins and outs of a nature-made PCSK9 inhibitor
Kardiomyozytäre Effekte der Proprotein Konvertase Subtilisin/Kexin Typ 9 (PCSK9)
Impact of PCSK9 inhibitors in glycaemic control and new-onset diabetes
PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention
Gene Therapy Targeting PCSK9
Makro Fotografie
Makro-Fotografie
Synthesis of a PCSK9 Inhibitor
PCSK9 inhibitors in the prevention of cardiovascular disease
Evolocumab (Repatha) - PCSK9-Inhibitor : kardiovaskuläre Risikioreduktion durch konsequente Lipidsenkung
Clinical Pharmacokinetics and Pharmacodynamics of Evolocumab, a PCSK9 Inhibitor
PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
Berberine : Ins and outs of a nature-made PCSK9 inhibitor
Kardiomyozytäre Effekte der Proprotein Konvertase Subtilisin/Kexin Typ 9 (PCSK9)
Impact of PCSK9 inhibitors in glycaemic control and new-onset diabetes
PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention
Gene Therapy Targeting PCSK9
Makro Fotografie